Public health policy and guidelines for management of Asthma

Currently, 300 million people suffer from asthma globally, of that one-tenth reside in India. Nearly 4,89,000 people die annually due to asthma. Majority of fatalities occur in low- and middle-income countries, such as the Middle East and Africa (Masoli et al., 2004). Also, people with asthma in low- and middle-income countries suffer more severe symptoms in comparison to those in high-income countries. This is because of inaccurate diagnoses, no or less availability of health care, and financial incompetence for treatment (Kant, 2013). Furthermore, the concern increases as the complexity and severity of allergic diseases continue to increase especially in children and young adults (WAO, 2011). This sudden upsurge of allergic diseases calls for an inspection of existing health policy measures to counter the issue.

Global policy scenario

Asthma has been regarded as an incurable disease, demanding appropriate management. To ensure a good quality of life, it is imperative for sufficient policy structures to be in place. This necessitates the execution of relevant measures for prevention and control of the disease.

International Collaboration in Asthma, Allergy, and Immunology (iCAALL), is a joint effort by the American Academy of Allergy Asthma and Immunology (AAAAI), the European Academy of Allergy and Clinical Immunology (EAACI), the American College of Allergy Asthma and Immunology (ACAAI) and the World Allergy Organization (WAO). The consortium promotes knowledge and raises awareness at different levels.

Global Initiative on Asthma (GINA), Launched in 1995 as a collaborative effort between the National Heart, Lung and Blood Institute (NHLBI) and the World Health Organization (WHO). A new update of the GINA guidelines emphasizes on disease control. Besides enlightenment upon therapeutic options, it also spreads awareness about Asthma-COPD overlap. In order to reduce the global burden of asthma, the guidelines design stimulates the implementation of practical guidelines  (Bousquet et al., 2007).

White Book on Allergy (WAO) reports statistics on the growing epidemic of allergy worldwide. It also offers a set of recommendations the “Declaration of Recommendations for governments and health care policy makers (Pawankar, 2014).

Important global policy and guidelines about Asthma

Important global policy and guidelines about Asthma

Policy scenario in India

Indian guidelines for asthma, a collaborative initiative by the Indian Chest Society (ICS) and the National College of Chest Physicians (NCCP); offers an evidence-based outline for general and pulmonary physicians for the diagnosis and management of asthma in general (Koul & Patel, 2015). The recommendations follow grade classification system, which forms the basis for the recommendation. The power of the guidelines lies in the evidence-based approach. RCTs and meta-analysis form the basis of approach for management, diagnosis, and treatment guidelines. However, certain shortcomings of the guidelines involve lack of consideration of practice settings. Furthermore, the local differences in availability and cost of therapies are also not taken into account. This document is the sole guideline governing asthma management in a large country with world’s second highest population.

Policy scenario in the USA

The USA leads India in policy formulation for asthma management, with a number of non-profitable organizations. The various federal and state government agencies along with these organization undertake the issues of policy legislation.

Organizations

Purpose

Asthma and Allergy Foundation of America Supporting policies aimed towards improved access to healthcare, promoting medical research, and high quality of life for people suffering from Asthma
Allergy and Asthma Network, Mothers of Asthmatics Network of families dedicated to offering information about living with asthma, and the relevant policy issues
American Lung Association Working with the mission to prevent lung diseases and promoting lung health. The organizational programs aim to influence the development and enforcement of laws and regulations at national, state, and local level. Thereby helping policymakers with authoritative information.
CDC’s Public Health Law Program Working with the mission to improve public health through law. It also offers resources dedicated to public health issues, especially focused on asthma.
Department of Health and Human Services Healthy People 2020 national health objectives for asthma dedicated to the promotion of respiratory health facilitated through prevention, detection, treatment, and educational efforts.

Table 1: Initiatives for prevention, management, and treatment of Asthma in the USA

Other relevant policy measures include Global Allergic Rhinitis and its Impact on Asthma guideline (ARIA). provides an evidence-based practice for management of AR. It has recently been updated using GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) methodology (Brożek et al., 2017). National Asthma Policy Agenda works towards the development of public policy agenda to reduce morbidity and mortality due to asthma.

Future needs

The policy management of non-communicable diseases, such as Asthma, needs to be addressed in a similar fashion as the communicable diseases. These are communicated by global promotion of products and lifestyles, lest they insidiously undermine the health and wealth of nations. The high, middle and low income countries need to collaborate to counter the increasing mortality rates and economic burdens. Additionally, worldwide solutions need to focus on generalizable preventive and curative solutions. With respect to India, to accomplish this shared purpose it is important to recognize the need to decrease the allergy burden. The large population demands development of cost-effective innovative preventive strategies. Hence, a highly integrated, holistic approach, such as shown by the USA can help lower mortality rates simultaneously enhancing the quality of life.

References

  • Bousquet, J., Clark, T.J.H., Hurd, S. & Khaltaev, N., 2007. GINA guidelines on asthma and beyond. allergy, 62, pp.102-12.
  • Brożek, J.L. et al., 2017. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision.
  • Kant, S., 2013. Socio-economic dynamics of asthma. Indian Journal of Medical Research, 138(4), pp.446–48.
  • Koul, P.A. & Patel, D., 2015. Indian guidelines for asthma: Adherence is the key. Lung India, 32(1), pp.S1–S2.
  • Masoli, Fabian, Holt & Beasley, 2004. The global burden of asthma: executive summary of the GINA Dissemination Committee report. allergy, 59(5), pp.469-78.
  • Pawankar, R., 2014. Allergic diseases and asthma: a global public health concern and a call to action. WAO Journal, 7(1), p.12.
  • WAO, 2011. Allergic Diseases: A Global Public Health Concern.

Laiba Siddiqui

Research Analyst at Project Guru
Laiba holds a bachelor’s degree in homoeopathy medicine and surgery. Coming from the medicine field she has an academic approach towards biology and biotechnology topics.She has the strengths of good R&D which makes her writing elaborate, accurate and detailed. She is well-read and well-informed. She wants to keep learning about different areas relevant to her field of work which keeps her committed to the work. Her hobbies are cooking, reading and traveling.

Related articles

  • Allergic asthma in developing and developed regions around the globe Allergic asthma a well-known chronic disease, of heterogeneous nature, affects respiratory airways. It presents several phenotypes on the basis of the disease progress. These phenotypes form recognizable demographic and clinical clusters around the glob
  • Cost of treatment care for allergic disorders It is essential to discuss the economics associated with the different treatment options. This demands the exploration of the cost of illness also known as the burden of disease.
  • Allergic diseases and its prevalence across 5 major countries Allergic diseases are a major health problem across the world. The global prevalence of allergic diseases has increased tremendously affecting 10-30% of the global population (Ring 2012). Apart from health problems, allergic diseases are also a major socio-economic burden of a country.
  • Social and economic burden of allergic diseases in India Allergic reactions in present times are affecting nearly 20-30% of the Indian population. Allergy has become a cause of concern for both individuals and government. This is because of its social and economic impact in terms of cost of healthcare, loss of working hours and lower quality […]
  • Economic burden from Asthma in India and USA Asthma presented substantial global burden, affecting 358.2 million people in 2015. A complex disease, it impairs the social, physical and psychological well-being of the affected. Furthermore, the asthmatic condition can be differentiated into controlled, partially controlled and […]

Discuss

We are looking for candidates who have completed their master's degree or Ph.D. Click here to know more about our vacancies.